Thulani H. Senanayake

Statistics

Publications

Citations

466

H-Index

Active since

2011

Affiliations

University of Nebraska Medical Center(Current)

Nebraska Medical Center

Thulani H. Senanayake is an author at University of Nebraska Medical Center specializing in pharmacology, drug delivery, and nanoparticle drug delivery.

Publications per year

2011–2017

Publications

Hyaluronic Acid-Based Nanogel–Drug Conjugates with Enhanced Anticancer Activity Designed for the Targeting of CD44-Positive and Drug-Resistant Tumors

Xin Wei, Thulani H. Senanayake, Galya Warren et al. · Bioconjugate Chemistry · 2013 · 192 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Targeted Nanogel Conjugate for Improved Stability and Cellular Permeability of Curcumin: Synthesis, Pharmacokinetics, and Tumor Growth Inhibition

Xin Wei, Thulani H. Senanayake, Anna Bohling et al. · Molecular Pharmaceutics · 2014 · 83 citations

Pharmacy, Oncology, Pharmacology +17

Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain

Trevor Gerson, Edward Makarov, Thulani H. Senanayake et al. · Nanomedicine Nanotechnology Biology and Medicine · 2013 · 57 citations

Life Sciences, Neuroscience, Pharmacology +14

Novel Anticancer Polymeric Conjugates of Activated Nucleoside Analogues

Thulani H. Senanayake, Galya Warren, Serguei V. Vinogradov · Bioconjugate Chemistry · 2011 · 36 citations

Medicine, Oncology, Pharmacology +17

Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates

Thulani H. Senanayake, Galya Warren, Xin Wei et al. · Journal of Controlled Release · 2013 · 36 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 8